MedTrace Logo

Anti-gingivitis Mouthrinse

NCT06048627 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-05-21

No results posted yet for this study

Summary

The purpose of this study is to prove whether a fluoride/zinc lactate containing mouthrinse is able to reduce dental plaque and gingival inflammation in patients who have gingivitis when applied twice daily during brushing at home over a period of 12 weeks.

Conditions

  • Gingivitis

Interventions

DRUG

Amine/zinc lactate/fluoride system

Amine/zinc lactate/fluoride system (250 ppm F), meridol®, Colgate-Palmolive

DRUG

negative control

Sodium fluoride mouthwash 250 ppm

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-06
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06048627 on ClinicalTrials.gov